Willingdon Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-107
| Closed | -$9K | – | 378 |
|
|
2018
Q4 | $9K | Sell |
107
-465
| -81% | -$39.1K | ﹤0.01% | 267 |
|
|
2018
Q3 | $98K | Hold |
572
| – | – | 0.03% | 160 |
|
|
2018
Q2 | $74K | Sell |
572
-25,028
| -98% | -$3.24M | 0.02% | 167 |
|
|
2018
Q1 | $2.64M | Buy |
25,600
+1,435
| +6% | +$148K | 0.83% | 50 |
|
|
2017
Q4 | $2.06M | Buy |
24,165
+633
| +3% | +$54.1K | 0.68% | 62 |
|
|
2017
Q3 | $2M | Buy |
23,532
+763
| +3% | +$64.8K | 0.73% | 61 |
|
|
2017
Q2 | $1.72M | Buy |
22,769
+309
| +1% | +$23.4K | 0.68% | 70 |
|
|
2017
Q1 | $1.48M | Buy |
22,460
+1,021
| +5% | +$67.4K | 0.6% | 68 |
|
|
2016
Q4 | $1.36M | Buy |
21,439
+767
| +4% | +$48.6K | 0.64% | 65 |
|
|
2016
Q3 | $1.32M | Buy |
20,672
+7,050
| +52% | +$449K | 0.66% | 72 |
|
|
2016
Q2 | $1.01M | Buy |
13,622
+1,067
| +8% | +$79.4K | 0.52% | 79 |
|
|
2016
Q1 | $839K | Sell |
12,555
-6,885
| -35% | -$460K | 0.51% | 69 |
|
|
2015
Q4 | $1.32M | Buy |
19,440
+847
| +5% | +$57.3K | 1.2% | 42 |
|
|
2015
Q3 | $993K | Sell |
18,593
-175
| -0.9% | -$9.35K | 1.18% | 42 |
|
|
2015
Q2 | $1.18M | Buy |
+18,768
| New | +$1.18M | 1.13% | 45 |
|